Loading
Small countries pay more for the same generic chemotherapy because they buy alone; the PAHO Strategic Fund and the WHO essential medicines list show that buying together brings prices down and keeps supply steady.
The WHO Model List of Essential Medicines (24th list, 2025) includes a core set of cancer medicines. The PAHO Strategic Fund is a regional pooled-procurement mechanism for essential medicines that member states can use; the Global Platform for Access to Childhood Cancer Medicines (WHO and St. Jude) applies the model to paediatric oncology. Extending pooled procurement to the adult essential-medicines set (platinums, taxanes, anthracyclines, imatinib, tamoxifen, letrozole, trastuzumab biosimilars) would give middle-income countries the prices large buyers get and reduce shortages.
Shares WHO Essential Medicines List for cancer, World Health Organization Cancer Programme, Imatinib, Prices and value.
Shares Imatinib, Prices and value, Most of the world has almost no cancer care, Paclitaxel / nab-paclitaxel.
Shares Letrozole (and other aromatase inhibitors), Tamoxifen, Imatinib, Prices and value.
Shares Imatinib, Prices and value, Most of the world has almost no cancer care.
Shares Imatinib, Prices and value, Most of the world has almost no cancer care.
Shares Imatinib, Prices and value, Most of the world has almost no cancer care.
Shares WHO Essential Medicines List for cancer, World Health Organization Cancer Programme, Prices and value, Most of the world has almost no cancer care.
Shares WHO Essential Medicines List for cancer, Imatinib, Prices and value, Most of the world has almost no cancer care.